Incisive Genetics Inc.
$132,000.00 CAD
≈ 20 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- June 1, 2020 – March 22, 2021
- Reference
- nrc-cnrc:172-2020-2021-Q2-952759
Published purpose
This project will involve determining optimal route of administration of Transfection Competent Vesicle (TCV) delivery of gene editing machinery in vivo efficacy studies to generate critical proof of concept data, advance internal drug development and initiate possible pharma partnering opportunities.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions